UCSF researchers engineered CAR-T cells that switch on only inside the brain. In mice, they cleared diffuse midline glioma, a deadly childhood brain cancer. Here is how it works, and why human trials still lie ahead.
UCSF researchers engineered CAR-T cells that switch on only inside the brain. In mice, they cleared diffuse midline glioma, a deadly childhood brain cancer. Here is how it works, and why human trials still lie ahead.